Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Japanese researchers describe anticoagulants

Feb. 27, 1997

Thrombin inhibitors from Merck & Co.

Feb. 26, 1997

Phase I study of pentosan polysulfate in cancer patients

Feb. 25, 1997

Centocor seeks expansion of ReoPro indications

Feb. 21, 1997

Fibrinogen antagonists from Glaxo Wellcome

Feb. 21, 1997

New dosage strengths of Coumadin available

Feb. 18, 1997

Ibustrin for diabetic vascular complications

Feb. 18, 1997

Ortho synthesizes inhibitors of serine proteases

Feb. 18, 1997

COR Therapeutics discloses factor Xa inhibitors

Feb. 18, 1997

Comparative study of second-generation t-PA inhibitor and alteplase

Feb. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...